Stonehouse Jon P

CIK 00013854963 companiesBIRMINGHAM, AL

SEC Profile

Transactions

Companies

Filings

CIK

0001385496

Recent Transactions

50 trades

Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-18+10,000→ 40,000 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-18−20,000→ 1,385,222 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-18+10,000→ 40,000 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-12-12$7.57/sh−27,368→ 1,405,222 total
Disposition to Issuer
Metsera, Inc.$MTSR
Stock Option (right to buy)
2025-11-13−47,730→ 0 total
Disposition to Issuer
Metsera, Inc.$MTSR
Common Stock
2025-11-13−2,688→ 0 total
Award
Metsera, Inc.$MTSR
Restricted Stock Unit
2025-11-13+2,688→ 2,688 total
Award
Metsera, Inc.$MTSR
Stock Option (Right to Buy)
2025-04-28$19.81/sh+47,730→ 47,730 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-20−20,000→ 1,429,109 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-20+10,000→ 30,000 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-20+10,000→ 30,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2024-12-19+750,250→ 750,250 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-19$7.39/sh−14,010→ 1,449,109 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-19+362,100→ 1,463,119 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-14$7.53/sh−27,525→ 1,101,019 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-05-13$5.55/sh+30,000→ 1,127,770 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-01-03+10,000→ 20,000 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-01-03−20,000→ 1,094,770 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-01-03+10,000→ 20,000 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-19$6.05/sh−14,089→ 1,114,770 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-14$6.43/sh−13,592→ 1,128,859 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2023-12-14+595,000→ 595,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-14+127,500→ 1,142,451 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-06-13−25,000→ 1,014,794 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2023-03-21−31,055→ 305,995 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-03-21$3.22/sh+31,055→ 1,039,794 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2023-02-01−100,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-02-01$5.45/sh+100,000→ 1,108,739 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-02-01$10.38/sh−100,000→ 1,008,739 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2023-01-03+121,452→ 204,086 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-29+5,000→ 10,000 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-29+5,000→ 10,000 total
Gift
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-29−10,000→ 1,008,739 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-19+127,500→ 1,015,230 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2022-12-19+595,000→ 595,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-15$10.90/sh−14,100→ 887,730 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2022-12-02−82,656→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-02$1.42/sh+82,656→ 984,486 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-02$12.80/sh−82,656→ 901,830 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2022-12-01−214,917→ 82,656 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-01$13.00/sh−214,917→ 901,830 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-01$1.42/sh+214,917→ 1,116,747 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2022-09-01+60,580→ 82,634 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2022-09-01+60,580→ 103,688 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2022-06-15+15,000→ 15,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-01-11$15.04/sh−184,000→ 901,602 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-01-11$4.73/sh+184,000→ 1,085,602 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2022-01-11−184,000→ 0 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2022-01-04+21,504→ 22,504 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2022-01-04−21,504→ 0 total

Companies

Recent Filings

Address

2190 PARKWAY LAKE DRIVE

BIRMINGHAM, AL, 35244-

View on SEC.gov